Background: Kounis syndrome is defined as a combination of acute coronary syndrome and allergic reactions. Objective: In this review, we aim to describe the etiological, clinical, and diagnostic characteristics of Kounis syndrome. Methods: A literature search using PubMed was conducted for the past 32 years using keywords, resulting in the selection of 761 scientific papers. From these, 217 articles describing 235 clinical cases were selected. Patients under 18 years of age or without a confirmed diagnosis were excluded. Results: Among the 235 patients, type I Kounis syndrome was observed in 49.7%, type II in 27.2%, type III in 5.9%, and a combination of types I and II in 1.0%; in 16.2%, it was not possible to classify the type of Kounis syndrome. The median age was 57 years, and 68.5% of the patients were male. The most common causes were antibiotics (32.3%) and non-steroidal anti-inflammatory drugs (24.3%). The clinical features included chest pain (59.1%), hypotension (74.2%), itching (30.6%), and dyspnea (30.6%). Electrocardiographic monitoring revealed ST-segment elevation in 42.9% and was normal in only 5.5% of patients. Coronary angiography was performed in 80.4% of the patients, revealing unchanged coronary arteries in 50.3% of cases. Сonclusion: Allergic myocardial infarction is a serious complication of drug therapy.
3 April 2023 in I.P. Pavlov Russian Medical Biological Herald
INTRODUCTION: Myocardial bridging (MB) is considered a benign pathology, however, its existence is often associated with angina pectoris, myocardial infarction, ventricular tachycardia and sudden cardiac death. The clinical significance of MB is determined by the dynamic stenosis of the coronary artery, which depends on the rate and strength of heart contractions and is poorly visualized by instrumental methods, which impairs timely diagnosis and early administration of the adequate treatment. A clinical case of a combined damage to the coronary bed in a 58-year-old patient is presented: MB of the anterior interventricular artery (AIVA) causing dynamically significant narrowing of the tunnel artery and hemodynamically insignificant atherosclerotic lesion of the coronary arteries. MB was typically located in the mid-segment of the AIVA. The diagnosis of the anomaly of the coronary bed was established after coronary angiography: MB of AIVA led to stenosis of the tunnel segment to 80% and was the cause of angina attacks. Stenting of the AIVA with a drug-coated stent was performed. The effectiveness of the stenting can be referred to a peculiar feature of this case, since in the treatment of this pathology the preference is given to myotomy and coronary artery bypass grafting as more effective methods. The follow-up period was 7.5 years; after stenting of the tunnel segment of the AIVA the anginal attacks did not recur. CONCLUSION: The described clinical case demonstrates the role of MB in the development of myocardial ischemia. With timely diagnosis of the coronary blood flow disorders, successful revascularization and adequate pharmacotherapy in accordance with the current clinical recommendations, the prognosis is good.
Introduction. Allergic reactions and side effects are a common consequence of drug use and account for ~5% of all hospital admissions. The co-occurrence of ana phylactic shock and acute myocardial infarction (AMI) is called Kounis synd rome (KS).Brief description. The article analyzes the case of ceftriaxone-induced KS in a 56-year-old female patient with a history of anaphylactic shock after ampicillin therapy. The patient was treated on an outpatient basis due to an acute upper respiratory infection. The patient was diagnosed with acute bronchitis, in connection with which antibiotic therapy with azithromycin was started. Due to inefficiency the drug was canceled and ceftriaxone 1 g in 3,5 ml of 1% lidocaine solution 2 times a day was prescribed. After the first intramuscular injection, the patient developed anaphylactic shock, which was stopped by intravenous administration of prednisolone 120 mg, dexamethasone 8 mg and adrenaline hydrochloride 1,0 ml. Almost immediately, the ST segment elevation was recorded, in connection with which thrombolytic therapy with fortelyzin 15 mg was performed. Coronary angiography revealed thrombotic occlusion of the left anterior descending artery in the upper segment. Further examination verified AMI in the patient.Discussion. This case of AMI is pathogenetically associated with anaphylactic shock. However, the available data on the state of patient coronary system and no data on the morphologic characteristics of thrombus do not make it possibelr to define a type of KS.Conclusion. This clinical case indicates the need for a thorough allergic anamnesis collection by physicians of any specialty and prescribing medications taking it into account.
27 July 2023 in Rational Pharmacotherapy in Cardiology
The article analyzes the case of the development of ventricular tachycardia and type 2 myocardial infarction (MI) in an 80-year-old patient with a history of coronary artery disease, MI and chronic heart failure. In 2020, the patient was diagnosed with ventricular extrasystole and started antiarrhythmic therapy with diethylamino propionylethoxycarbonylaminophenothiazine 150 mg per day and sotalol 160 mg per day. In 2022, the patient had an episode of clinical death due to ventricular tachycardia with successful resuscitation. A diagnosis of non-ST-elevation acute coronary syndrome was made, coronary angiography was performed, which did not reveal significant coronary stenosis. Upon further examination, the dynamics of biomarkers of myocardial necrosis confirmed the diagnosis of acute MI. In the analyzed case, the development of ventricular tachycardia and MI is most likely associated with the intake of diethylaminopropionylethoxycarbonylaminophenothiazine in combination with sotalol, prescribed in the presence of contraindications to their use.
5 May 2025 in Russian Journal of Geriatric Medicine
RELEVANCE. The STEMI-NSTEMI paradigm officially replaced the Q- and non-Q-wave myocardial infarction (MI) paradigm in 2000. This paradigm shift was driven by the reperfusion era, when several large randomized controlled trials demonstrated the efficacy of emergency reperfusion therapy, primarily with thrombolytic therapy. It was therefore necessary to identify patients who would benefit most from such treatment, and it turned out that these were patients with ST-segment elevation on the electrocardiogram (ECG), since such ECG changes in combination with clinical signs and/or symptoms of myocardial ischemia are highly suggestive of coronary artery (CA) occlusion.However, coronary artery occlusion can be detected not only in patients with acute coronary syndrome (ACS) with ST segment elevation on the ECG, but also in patients with ACS without ST segment elevation on the ECG, as evidenced by the studies of Almendro-Delia M. (2020), Balbi M. M. (2021), Bruno F. (2023), Mohammad A. M. (2024). In this regard, it seems appropriate to analyze the data of patients with MI not only depending on the presence of ST segment elevation on the ECG but also depending on the presence of coronary artery occlusion. This is especially important in patients whose ECG interpretation is difficult: patients with rhythm and conduction disorders, with post-infarction cardiosclerosis, diabetes mellitus, elderly and senile age. It is noteworthy that there are no works devoted to the study of MI with occlusive coronary lesions in patients aged 75 years and older in the available literature.
30 June 2025 in Rational Pharmacotherapy in Cardiology
Given the high prevalence of allergic and cardiovascular diseases, clinicians must remain vigilant to the possibility of Kounis syndrome (KS), which involves the cooccurrence of an allergic reaction and acute myocardial infarction (AMI). The article describes a case of KS in a 62-year-old patient, without atherosclerotic coronary artery disease, during the infusion of a plasma-substitute, dextran, used by the patient for self-medication and resulting anaphylactic shock. The diagnosis of AMI was confirmed by elevated myocardial necrosis biomarkers, as well as electrocardiographic and echocardiographic changes. Patient management adhered to current clinical guidelines for AMI and allergic reactions. The distinctive feature of this clinical case is the development of type I KS triggered by dextran, and the multifactorial etiology of AMI. This case demonstrates the importance of recognising KS, advocates for restricting self-treatment practices, and highlights the need for preventive counselling regarding its potential consequences.